Naviter Wealth’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Naviter Wealth's BMY Position: Q1 2026 in Review
Naviter Wealth reduced its Bristol-Myers Squibb (BMY) stake by 14% in Q1 2026, selling an estimated $36.3K and leaving 3,933 shares worth $239K. The position accounts for 0.03% of the portfolio, ranked #256.
Naviter Wealth first reported a position in BMY in Q2 2022 and has held it in 16 quarters since. The position peaked at $1.68M in Q3 2024. 2,519 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Naviter Wealth held 3,933 shares of Bristol-Myers Squibb worth $239K as of Q1 2026.
- Naviter Wealth sold 622 Bristol-Myers Squibb shares in Q1 2026, an estimated $36.3K.
- Bristol-Myers Squibb made up 0.03% of Naviter Wealth's portfolio in Q1 2026, its #256 holding.
- Naviter Wealth first reported a position in Bristol-Myers Squibb in Q2 2022 and has held it in 16 quarters since.
- Naviter Wealth's Bristol-Myers Squibb position peaked at $1.68M in Q3 2024.
- 2,519 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Naviter Wealth's 13F filing for Q1 2026, filed 10 Apr 2026.